Meningitis Encephalitis: a Metagenomics-Based Etiology & Epidemiology Research
NCT04724876 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2021-01-26
Summary
Autoimmune encephalitis (AE) is caused by abnormal immune response mediated by autoimmune antibodies of patients, which can be detected by a serial of autoimmune antibodies\[4,5,6,7\]. At present, the traditional infection diagnosis mainly relies on microbial culture method, which has the characteristics of long cycle, high cost, low detection rate and complex detection process. About 30-60% of encephalitis have unknown etiology\[2,3\]. On the other hand, the diagnosis and classification of noninfectious encephalitis mainly depend on the detection of autoimmune antibodies, the scope of diagnosis and differential diagnosis is limited, and the relationship between autoimmune encephalitis and infection factors is still unclear. Metagenomics sequencing (mNGS) is a new method that does not rely on microbial culture and can directly detect pathogenic nucleic acids. It has the characteristics of fast, accurate, high throughput, no preference for different pathogen detection, and can detect known and unknown pathogens at the same time. Nowadays, mNGS is widely used in the field of pathogen detection.
Conditions
- Central Nervous System Infections and Inflammations
Sponsors & Collaborators
-
Beijing Tiantan Hospital
collaborator OTHER -
Air Force Military Medical University, China
collaborator OTHER -
Peking Union Medical College Hospital
collaborator OTHER -
The Second Hospital of Hebei Medical University
collaborator OTHER -
First Affiliated Hospital, Sun Yat-Sen University
collaborator OTHER -
Chinese PLA General Hospital
collaborator OTHER -
Xuanwu Hospital, Beijing
collaborator OTHER -
Third Affiliated Hospital, Sun Yat-Sen University
collaborator OTHER -
Shandong Provincial Hospital
collaborator OTHER_GOV -
Fudan University
collaborator OTHER -
West China Hospital
collaborator OTHER -
Henan Provincial People's Hospital
collaborator OTHER -
Central South University
collaborator OTHER -
The First Affiliated Hospital of Shanxi Medical University
collaborator OTHER -
Beijing Tongren Hospital
lead OTHER
Principal Investigators
-
Jiawei Wang, Doctor · Beijing Tong Ren Hospital
Eligibility
- Min Age
- 14 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-12-31
- Primary Completion
- 2023-06-30
- Completion
- 2023-06-30
Countries
- China
Study Locations
More Related Trials
-
Metabolic Imaging for Diagnosis and Prognostication of Autoimmune encephalitiS
NCT06432803 ·Status: ACTIVE_NOT_RECRUITING
-
Clinical Characteristics of Patients With Anti-Collapsin Response Mediator Protein 2 Antibodies in Encephalitis or Encephalomyelitis
NCT07036042 ·Status: COMPLETED
-
Multicenter and Prospective Clinical Registry Study of Anti-N-methyl-D-aspartate Receptor Encephalitis in China
NCT02559089 ·Status: UNKNOWN
-
To Explore Cognitive Neural Mechanism of Autoimmune Encephalitis by Using Neuropsychological Tests and Multi-modal MRI
NCT03530462 ·Status: COMPLETED
-
The Diagnostic Value of Autoimmune Antibody Detection in Newly Onset and Chronic Epilepsy
NCT04516590 ·Status: UNKNOWN
-
HLA Analysis in Autoimmune Encephalitis and Related Disorders: Part II
NCT04823728 ·Status: RECRUITING
-
Developing Advanced Neuroimaging for Clinical Evaluation of Autoimmune Encephalitis
NCT05280600 ·Status: RECRUITING
-
HLA Analysis in Autoimmune Encephalitis and Related Disorders
NCT04106596 ·Status: UNKNOWN
-
BRIEF TITLE * (in English and Sufficiently Descriptive) Role of MRI in Anti-LGI1 Encephalitis
NCT05825690 ·Status: COMPLETED
-
Multicenter and Prospective Clinical Registry Study of Anti-N-methyl-D-aspartate Receptor Encephalitis in Beijing Area
NCT02443350 ·Status: UNKNOWN
-
Biological Markers for the Diagnosis of Central Nervous System Infective Diseases
NCT02278016 ·Status: UNKNOWN
-
Clinical Features and Prognostic Markers in Adult Patients With AE Requiring ICU Treatment
NCT06456736 ·Status: NOT_YET_RECRUITING
-
Characterization of Immune-response in Autoimmune Encephalitis and Paraneoplastic Neurological Syndromes
NCT05772611 ·Status: RECRUITING
-
Molecular Panel Evaluation for Diagnosis of Infections of the Central Nervosous System
NCT06720519 ·Status: COMPLETED
-
Neural Autoantibody Prevalence in New-onset Focal Seizures of Unknown Etiology
NCT06388161 ·Status: RECRUITING
-
Autoimmune Encephalitis With Anti-NMDA Receptor Antibodies Following Herpetic Encephalitis
NCT04339127 ·Status: UNKNOWN
-
Diffusion Imaging in Acute Auto-immune Encephalitis
NCT04339205 ·Status: UNKNOWN
-
Neuroimmunology Registry and Biobank
NCT06958341 ·Status: RECRUITING
-
A Prospective Study to Evaluate Clinical Outcomes in Anti-LGI1 Encephalitis
NCT06173076 ·Status: RECRUITING
-
Predicting and Monitoring Outcomes in Autoimmune Encephalitis
NCT05711563 ·Status: NOT_YET_RECRUITING
-
FDG-PET in the Diagnosis of Autoimmune Encephalitis
NCT06019975 ·Status: RECRUITING
-
Inflammatory and Infectious Diseases of the Nervous System
NCT02435810 ·Status: RECRUITING
-
TSPO-PET/MRI in Surveillance of Neuroinflammation in the Central Nervous System
NCT06467773 ·Status: RECRUITING
-
Precision Diagnosis of Acute Infectious Diseases; Neuroinflammatory Cohort
NCT02910037 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Rituximab in the Treatment of Anti-Vimentin Antibody-associated Diseases
NCT07051070 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4